Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
7/21/2025
/ Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
OPPS ,
Physician Fee Schedule ,
Proposed Rules ,
Public Health
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/14/2025
/ Budget Cuts ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Health Care Providers ,
Healthcare Facilities ,
Healthcare Reform ,
Hospitals ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Proposed Legislation ,
Proposed Rules
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
3/31/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Healthcare Reform ,
HRSA ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
New Regulations ,
Trump Administration ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
3/17/2025
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare Facilities ,
Healthcare Fraud ,
Medicaid ,
Medicare ,
Prescription Drugs
Our Health Care Group breaks down two California bills (SB 351 and AB 1415) that would regulate private equity’s and hedge funds’ roles in managing health care and dental practices....more
3/6/2025
/ Business Entities ,
California ,
Dental Practice ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Investors ,
New Legislation ,
Non-Compete Agreements ,
Private Equity ,
Regulatory Requirements
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
2/24/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Facilities ,
Medicaid ,
Medicare ,
Public Health ,
Regulatory Requirements ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
12/23/2024
/ AHRQ ,
Centers for Disease Control and Prevention (CDC) ,
Clinical Laboratories ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
HRSA ,
Life Sciences ,
National Institute of Health (NIH) ,
Public Health
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
12/9/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
HRSA ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
10/29/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
HRSA ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Pharmaceutical Industry ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
10/14/2024
/ Assisted Living Facilities (ALFs) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Prescription Drugs ,
Request For Information
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
10/7/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Hospitals ,
Inpatient Prospective Payment System (IPPS) ,
Medicare ,
Public Health
Private equity groups looking to invest in California’s health care industry breathed a sigh of relief when the governor vetoed California’s AB 3129. Our Health Care Group explains why health care transactions in the state...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
9/30/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Healthcare Facilities ,
Life Sciences ,
Medicaid ,
Medicare ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
9/23/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
HRSA ,
Medicaid ,
Medicare ,
Mental Health ,
MHPAEA ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
9/9/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
HRSA ,
Medicaid ,
Medical Devices ,
Medicare ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
8/26/2024
/ Abbreviated New Drug Application (ANDA) ,
Centers for Disease Control and Prevention (CDC) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
HIV ,
HRSA ,
Medical Devices ,
Mental Health ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health Service (PHS) ,
SAMHSA ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
8/19/2024
/ AHRQ ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Hospitals ,
Medical Devices ,
Medicare ,
Medicare Part D ,
Pharmaceutical Industry ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
8/12/2024
/ Animal Food ,
Biologics ,
Cancer ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
HRSA ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Pharmaceutical Industry ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
8/5/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Food and Drug Administration (FDA) ,
Food Safety ,
Generic Drugs ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Hospice ,
Hospitals ,
Inpatient Rehab Facilities ,
Long Term Care Facilities ,
Medicaid ,
Medical Devices ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs ,
Psychiatric Hospitals ,
SAMHSA ,
Skilled Nursing Facility
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
7/29/2024
/ Biosimilars ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Electronic Protected Health Information (ePHI) ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Medical Devices ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Public Health
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
7/22/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Facilities ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
SAMHSA
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
6/10/2024
/ Biologics ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Medicaid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Ransomware ,
Section 340B
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/15/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
HRSA ,
Long Term Care Facilities ,
Medicaid ,
Medicare ,
Medicare Advantage ,
National Institute of Health (NIH) ,
OIG ,
Popular ,
Skilled Nursing Facility ,
Telehealth
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/1/2024
/ Abbreviated New Drug Application (ANDA) ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Healthcare Facilities ,
Medicaid ,
Medical Devices ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
2/26/2024
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Medicaid ,
Medical Devices ,
Pharmaceutical Industry ,
Popular ,
Public Health Emergency